ZenBio, Inc. announced that it has been awarded a Phase I SBIR grant to develop novel stem cell-based therapeutics to treat tendinopathy that occurs with aging. The award from the National Institute on Aging...
Read More »ZenBio, Inc. announced that it has been awarded a Phase I SBIR grant to develop novel stem cell-based therapeutics to treat tendinopathy that occurs with aging. The award from the National Institute on Aging...
Read More »